Evaluating apatite formation and osteogenic activity of electrospun composites for bone tissue engineering

Biotechnology and Bioengineering

Volumn 111, Issue 5, 2014, Pages 1000-1017

  Patlolla, Ajitha ^a   Arinzeh, Treena Livingston ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bioceramic; Biocomposite; Electrospinning; Mesenchymal stem cell; Nanoceramic; Osteogenesis

Indexed keywords

APATITE; BIOCERAMICS; BIOCHEMISTRY; BONE; CALCIUM; CALCIUM PHOSPHATE; CELL CULTURE; CERAMIC MATERIALS; COMPOSITE MATERIALS; DICHLOROMETHANE; ELECTROSPINNING; GENE EXPRESSION; ORGANIC SOLVENTS; SOLVENTS; STEM CELLS; TISSUE;

BIO-COMPOSITES; CALCIUM PHOSPHATE CERAMICS; ELECTROSPINNING TECHNIQUES; HUMAN MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; NANO CERAMICS; OSTEOGENESIS; OSTEOGENIC DIFFERENTIATION;

SCAFFOLDS (BIOLOGY);

APATITE; CALCIUM PHOSPHATE CERAMIC; DICHLOROMETHANE; N,N DIMETHYLFORMAMIDE; NANOCERAMICS; NANOCOMPOSITE; POLYCAPROLACTONE; SOLVENT; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; BONE TISSUE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CELL STRUCTURE; DEGRADATION; ELECTROSPINNING; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; NANOFABRICATION; TISSUE ENGINEERING;

BIOCERAMIC; BIOCOMPOSITE; ELECTROSPINNING; MESENCHYMAL STEM CELL; NANOCERAMIC; OSTEOGENESIS;

CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DIMETHYLFORMAMIDE; DURAPATITE; ELECTROCHEMICAL TECHNIQUES; EXTRACELLULAR MATRIX; HUMANS; MESENCHYMAL STROMAL CELLS; METHYLENE CHLORIDE; NANOCOMPOSITES; OSTEOGENESIS; POLYESTERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84897046024     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25146     Document Type: Article

References (53)

1. Arellano-Jiménez MJ, García-García R, Reyes-Gasga J. 2009. Synthesis and hydrolysis of octacalcium phosphate and its characterization by electron microscopy and X-ray diffraction. J Phys Chem Solids 70(2):390-395.
2. Arinzeh TL, Tran T, McAlary J, Daculsi G. 2005. A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials 26(17):3631-3638.
3. Aro HT, Aho AJ. 1993. Clinical use of bone grafts. Ann Med 25:403-412.
4. Baksh D, Yao R, Tuan RS. 2007. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392.
5. Bellows CG, Heersche JN, Aubin JE. 1992. Inorganic phosphate added exogenously or released from beta-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone Miner 17(1):15-29.
6. Bishop GB, Einhorn TA. 2007. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthopaedic 31:721-727.
7. Bohner M, Lemaitre J. 2009. Can bioactivity be tested in vitro with SBF solution? Biomaterials 30:2175-2179.
8. Cahill KS, Chi JH, Day A, Claus EB. 2009. Prevalance, complications, and hospital charges associated with use of bone morphogenetic proteins in spinal fusion procedures. J Am Med Assoc 302:58-66.
9. Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res 9(5):641-650.
10. Cho SB, Miyaji F, Kokubo T, Nakanishi K, Soga N, Nakamura T. 1998. Apatite formation on silica gel in simulated body fluid: Effects of structural modification with solvent-exchange. J Mater Sci Mater Med 9(5):279-284.
11. Garrison KR, Donnell S, Ryder J, Shemilt I, Mugford M, Harvey I, Song F. 2007. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: A systematic review. Health Technol Assess 11:1-150.
12. Ghasemi-Mobarakeh L, Morshed M, Karbalaie K, Fesharaki M, Nasr-Esfahani MH, Baharvand H. 2008. Electrospun poly (ε{lunate}-caprolactone) nanofiber mat as extracellular matrix. Yakhteh 10(3):179-184.
13. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. 1992. Characterization of cells with osteogenic potential from human marrow. Bone 13(1):81-88.
14. Hench LL. 1991. Bioceramics: From concept to clinic. J Am Ceramic Soc 74(7):1487-1510.
15. Hench LL. 1998. Bioactive materials: The potential for tissue regeneration. J Biomed Mater Res 41(4):511-518.
16. Hench LL, Wilson J. 1993. An Introduction to bioceramics. Singapore; River Edge, NJ: World Scientific. x386 pp.
17. Hing KA, Wilson LF, Buckland T. 2007. Comparative performance of three ceramic bone graft substitutes. Spine J 7(4):475-490.
18. Ik SL, Oh HK, Meng W, Kang IK, Ito Y. 2004. Nanofabrication of microbial polyester by electrospinning promotes cell attachment. Macromol Res 12(4):374-378.
19. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64(2):295-312.
20. Jalota S, Bhaduri SB, Tas AC. 2006. In vitro testing of calcium phosphate (HA, TCP, and biphasic HA-TCP) whiskers. J Biomed Mater Res A 78(3):481-490.
21. Kim HW, Lee HH, Knowles JC. 2006a. Electrospinning biomedical nanocomposite fibers of hydroxyapatite/poly(lactic acid) for bone regeneration. J Biomed Mater Res A 79(3):643-649.
22. Kim SS, Park MS, Jeon O, Choi CY, Kim BS. 2006b. Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 27:1399-1409.
23. Kokubo T, Ito S, Huang ZT, Hayashi T, Sakka S, Kitsugi T, Yamamuro T. 1990. Ca, P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res 24(3):331-343.
24. Kokubo T, Takadama H. 2006. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 27:2907-2915.
25. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, Boyde A, Ruspantini I, Chistolini P, Rocca M, Giardino R, Cancedda R, Quarto R. 2000. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49(3):328-337.
26. Kubarev OL, Komlev VS, Barinov SM, Sergeeva NS, Sviridova IK, Kirsanova VA, Akhmedova SA, Solntsev KA. 2006. Bioceramic granules with controlled resorbability for bone tissue therapy. Doklady Chem 409(1):124-127.
27. Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, Scheideler M, Windhager R, Preisegger KH, Trajanoski Z. 2007. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 8:70.
28. Lao L, Wang Y, Zhu Y, Zhang Y, Gao C. 2011. Poly(lactide-co-glycolide)/hydroxyapatitie nanofibrous scaffolds fabricated by electrospinning for bone tissue engineering. J Mater Sci Mater Med 22:1873-1884.
29. Leng Y, Chen J, Qu S. 2003. TEM study of calcium phosphate precipitation on HA/TCP ceramics. Biomaterials 24(13):2125-2131.
30. Livingston Arinzeh T, Peter S, Archambault M, McIntosh K, van den Bos C, Gordon S, Young R, Kraus K, Kadiyala S, Smith A. 2003. Allogeneic mesenchymal stem cells regenerate bone in a critically-sized canine segmental gap. J Bone Joint Surg Am 85-A(10):1927-1935.
31. Lu HH, Tang A, Oh SC, Spalazzi JP, Dionisio K. 2005. Compositional effects on the formation of a calcium phosphate layer and the response of osteoblast-like cells on polymer-bioactive glass composites. Biomaterials 26(32):6323-6334.
32. Matthews JA, Wnek GE, Simpson DG, Bowlin GL. 2002. Electrospinning of collagen nanofibers. Biomacromolecules 3(2):232-238.
33. Mavis B, Demirtas TT, Gumusderelioglu M, Gunduz G, Colak U. 2009. Synthesis, characterization and osteoblastic activity of polycaprolactone nanofibers coated with biomimetic calcium phosphate. Acta Biomater 5(8):3098-3111.
34. Muller PY, Janovjak H, Miserez AR, Dobbie Z. 2002. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32(6):1372-1374; 1376, 1378-1379.
35. Oyane A, Uchida M, Choong C, Triffitt J, Jones J, Ito A. 2005. Simple surface modification of poly(epsilon-caprolactone) for apatite deposition from simulated body fluid. Biomaterials 26(15):2407-2413.
36. Patlolla A, Collins G, Arinzeh TL. 2010. Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration. Acta Biomater 6(1):90-101.
37. Petite H, Viateau V, Bensaïd W, Meunier A, de Pollak C, Bourguignon M, Oudina K, Sedel L, Guillemin G. 2000. Tissue-engineered bone regeneration. Nat Biotechnol 18(9):959-963.
38. Pham QP, Kasper FK, Scott Baggett L, Raphael RM, Jansen JA, Mikos AG. 2008. The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials 29(18):2729-2739.
39. Praemer A, Furner S, Rice DP. 1999. Musculoskeletal conditions in the United States: American Academy of Orthopaedic Sureons, 2nd edition. 182 pp.
40. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. 2003. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18(10):1842-1853.
41. Salgado AJ, Coutinho OP, Reis RL. 2004. Bone tissue engineering: State of the art and future trends. Macromolecules 4:743-765.
42. Sasso RC, LeHuec JC, Shaffrey C. 2005. Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: A prospective patient satisifactions outcome assessment. J Spinal Disord Tech 18:S77-S81.
43. Schneider O, Loher S, Brunner TJ, Uebersax L, Simonet M, Grass RN, Merkle HP, Stark WJ. 2008. Cotton wool-like nanocomposite biomaterials prepared by electrospinning: In vitro bioactivity and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res Part B 84B(2):350-362.
44. Song IH, Caplan AI, Dennis JE. 2009. Dexamathasone inhibition of confluence-induced apoptosis in human mesenchymal stem cells. J Orthop Res 27:216-221.
45. Stevenson S, Emery SE, Goldberg VM. 1996. Factors affecting bone graft incorporation. Clin Orthop Relat Res 324:66-74.
46. Tang R, Hass M, Wu W, Gulde S, Nancollas GH. 2003. Constant composition dissolution of mixed phases. II. Selective dissolution of calcium phosphates. J Colloid Interface Sci 260(2):379-384.
47. Vander Griend RA., 1994. The effect of internal fixation on the healing of large allografts. J Bone Joint Surg Am 76(5):657-663.
48. Wang H, Lin C, Hu R. 2009. Effects of structure and composition of the CaP composite coatings on apatite formation and bioactivity in simulated body fluid. Appl Surf Sci 255(7):4074-4081.
49. Xin R, Leng Y, Chen J, Zhang Q. 2005. A comparative study of calcium phosphate formation on bioceramics in vitro and in vivo. Biomaterials 26(33):6477-6486.
50. Yan X, Huang X, Yu C, Deng H, Wang Y, Zhang Z, Qiao S, Lu G, Zhao D. 2006. The in-vitro bioactivity of mesoporous bioactive glasses. Biomaterials 27(18):3396-3403.
51. Yang F, Wolke JGC, Jansen JA. 2008. Biomimetic calcium phosphate coating on electrospun poly(ε{lunate}-caprolactone) scaffolds for bone tissue engineering. Chem Eng J 137(1):154-161.
52. Ye F, Lu X, Lu B, Wang J, Shi Y, Zhang L, Chen J, Li Y, Bu H. 2007. A long-term evaluation of osteoinductive HA/β-TCP ceramics in vivo: 4.5 Years study in pigs. J Mater Sci 18:2173-2178.
53. Yeo A, Rai B, Sju E, Cheong JJ, Teoh SH. 2008. The degradation profile of novel, bioresorbable PCL-TCP scaffolds: An in vitro and in vivo study. J Biomed Mater Res Part A 84A(1):208-218.